We investigated the mRNA expression levels of six candidate genes (TAGLN2, WDR78, C4orf34, PNP, LASS2, and STXBP4) using PCa or non-PCa clinical specimens. The gene discussed is TAGLN2; the disease is posterior cortical atrophy.